Recent Updates on Outbreaks of Shiga Toxin-Producing Escherichia coli and Its Potential Reservoirs - PubMed
- ️Wed Jan 01 2020
Review
Recent Updates on Outbreaks of Shiga Toxin-Producing Escherichia coli and Its Potential Reservoirs
Jun-Seob Kim et al. Front Cell Infect Microbiol. 2020.
Abstract
Following infection with certain strains of Shiga toxin-producing Escherichia coli (STEC), particularly enterohemorrhagic ones, patients are at elevated risk for developing life-threatening extraintestinal complications, such as acute renal failure. Hence, these bacteria represent a public health concern in both developed and developing countries. Shiga toxins (Stxs) expressed by STEC are highly cytotoxic class II ribosome-inactivating proteins and primary virulence factors responsible for major clinical signs of Stx-mediated pathogenesis, including bloody diarrhea, hemolytic uremic syndrome (HUS), and neurological complications. Ruminant animals are thought to serve as critical environmental reservoirs of Stx-producing Escherichia coli (STEC), but other emerging or arising reservoirs of the toxin-producing bacteria have been overlooked. In particular, a number of new animal species from wildlife and aquaculture industries have recently been identified as unexpected reservoir or spillover hosts of STEC. Here, we summarize recent findings about reservoirs of STEC and review outbreaks of these bacteria both within and outside the United States. A better understanding of environmental transmission to humans will facilitate the development of novel strategies for preventing zoonotic STEC infection.
Keywords: HUS; STEC reservoir; Shiga toxin; Shiga toxin-producing Escherichia coli; environmental transmission.
Copyright © 2020 Kim, Lee and Kim.
Figures

After ingestion of food or water contaminated with pathogenic STEC, Stxs may cross the intestinal epithelial barrier via M-cell uptake and transcytosis or paracellular transport. Once in the submucosa, the toxins activate innate immune cells, such as neutrophils or monocytes that act as “carrier” cells to deliver Stxs in the bloodstream and may also further exacerbate tissue injury via localized production of proinflammatory cytokines. Ultimately, the toxins are transferred to glomerular endothelial cells and tubular epithelial cells, which are rich in the toxin receptor Gb3. Damage to the kidney, the primary target organ, leads to D + HUS (diarrhea-associated hemolytic uremic syndrome).
Similar articles
-
Bai X, Ylinen E, Zhang J, Salmenlinna S, Halkilahti J, Saxen H, Narayanan A, Jahnukainen T, Matussek A. Bai X, et al. Microbiol Spectr. 2022 Aug 31;10(4):e0066022. doi: 10.1128/spectrum.00660-22. Epub 2022 Jun 22. Microbiol Spectr. 2022. PMID: 35730965 Free PMC article.
-
Carter MQ, Pham A, Du WX, He X. Carter MQ, et al. Int J Food Microbiol. 2021 Feb 2;339:109029. doi: 10.1016/j.ijfoodmicro.2020.109029. Epub 2020 Dec 23. Int J Food Microbiol. 2021. PMID: 33360585
-
López EL, Contrini MM, Glatstein E, Ayala SG, Santoro R, Ezcurra G, Teplitz E, Matsumoto Y, Sato H, Sakai K, Katsuura Y, Hoshide S, Morita T, Harning R, Brookman S. López EL, et al. Pediatr Infect Dis J. 2012 Jan;31(1):20-4. doi: 10.1097/INF.0b013e31822ea6cf. Pediatr Infect Dis J. 2012. PMID: 21829137
-
Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection.
Bruyand M, Mariani-Kurkdjian P, Gouali M, de Valk H, King LA, Le Hello S, Bonacorsi S, Loirat C. Bruyand M, et al. Med Mal Infect. 2018 May;48(3):167-174. doi: 10.1016/j.medmal.2017.09.012. Epub 2017 Oct 18. Med Mal Infect. 2018. PMID: 29054297 Review.
-
Experimental In Vivo Models of Bacterial Shiga Toxin-Associated Hemolytic Uremic Syndrome.
Jeong YJ, Park SK, Yoon SJ, Park YJ, Lee MS. Jeong YJ, et al. J Microbiol Biotechnol. 2018 Sep 28;28(9):1413-1425. doi: 10.4014/jmb.1803.03012. J Microbiol Biotechnol. 2018. PMID: 29926707 Review.
Cited by
-
Alhadlaq MA, Aljurayyad OI, Almansour A, Al-Akeel SI, Alzahrani KO, Alsalman SA, Yahya R, Al-Hindi RR, Hakami MA, Alshahrani SD, Alhumeed NA, Al Moneea AM, Al-Seghayer MS, AlHarbi AL, Al-Reshoodi FM, Alajel S. Alhadlaq MA, et al. Gut Pathog. 2024 Oct 7;16(1):57. doi: 10.1186/s13099-024-00641-9. Gut Pathog. 2024. PMID: 39370525 Free PMC article. Review.
-
A novel Shiga toxin 2a neutralizing antibody therapeutic with low immunogenicity and high efficacy.
Kirkland ME, Patfield S, Hughes AC, Hernlem B, He X. Kirkland ME, et al. Antimicrob Agents Chemother. 2024 Jan 10;68(1):e0059823. doi: 10.1128/aac.00598-23. Epub 2023 Dec 4. Antimicrob Agents Chemother. 2024. PMID: 38047751 Free PMC article.
-
Cancer trigger or remedy: two faces of the human microbiome.
Grenda A, Krawczyk P. Grenda A, et al. Appl Microbiol Biotechnol. 2021 Feb;105(4):1395-1405. doi: 10.1007/s00253-021-11125-0. Epub 2021 Jan 25. Appl Microbiol Biotechnol. 2021. PMID: 33492450 Review.
-
Characterization of Atypical Shiga Toxin Gene Sequences and Description of Stx2j, a New Subtype.
Gill A, Dussault F, McMahon T, Petronella N, Wang X, Cebelinski E, Scheutz F, Weedmark K, Blais B, Carrillo C. Gill A, et al. J Clin Microbiol. 2022 Mar 16;60(3):e0222921. doi: 10.1128/jcm.02229-21. Epub 2022 Mar 16. J Clin Microbiol. 2022. PMID: 35225693 Free PMC article.
-
Liu Y, Thaker H, Wang C, Xu Z, Dong M. Liu Y, et al. Toxins (Basel). 2022 Dec 23;15(1):10. doi: 10.3390/toxins15010010. Toxins (Basel). 2022. PMID: 36668830 Free PMC article. Review.
References
-
- Beutin L. (1999). Escherichia coli as a pathogen in dogs and cats. Vet. Res. 30, 285–298. - PubMed
-
- Beutin L., Geier D., Steinruck H., Zimmermann S., Scheutz F. (1993). Prevalence and some properties of verotoxin (Shiga-like toxin)-producing Escherichia coli in seven different species of healthy domestic animals. J. Clin. Microbiol. 31, 2483–2488. 10.1128/JCM.31.9.2483-2488.1993 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical